• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

On the presence of a clorgyline resistant benzylamine oxidase activity in mouse kidney.

作者信息

Banchelli G, Buffoni F, Raimondi L

机构信息

Department of Pharmacology, University of Florence, Italy.

出版信息

Pharmacol Res Commun. 1988 Jun;20(6):465-83. doi: 10.1016/s0031-6989(88)80075-4.

DOI:10.1016/s0031-6989(88)80075-4
PMID:3138700
Abstract

In the crude homogenates of three different strains (C3H, Swiss, C57b) of mouse kidney the exposure to a millimolar concentration of clorgyline reveals a benzylamine oxidative deaminating activity that is due to a clorgyline resistant amine oxidase (CRAO). In the three strains this CRAO activity shows a low sensitivity to semicarbazide and to alpha- amiguanidine. In the C3H mouse kidney the glycoprotein nature of the CRAO was established from affinity chromatography with immobilized concanavalin A. Studies of this activity in the C3H mouse kidney revealed the presence of a reversible inhibitor which is precipitated by ammonium sulphate between 35-55% of saturation. The presence of this inhibitor precludes accurate measurement of the CRAO distribution in the different subcellular fractions. The enzyme purified by affinity chromatography, is semicarbazide insensitive. This is the first observation of the presence of a CRAO-semicarbazide insensitive activity in a tissue. The fact that "original homogenate" and the subcellular fractions show some sensitivity to semicarbazide also indicates that a semicarbazide-sensitive amine oxidase (SSAO) is present in the C3H mouse kidney.

摘要

相似文献

1
On the presence of a clorgyline resistant benzylamine oxidase activity in mouse kidney.
Pharmacol Res Commun. 1988 Jun;20(6):465-83. doi: 10.1016/s0031-6989(88)80075-4.
2
In vitro and in vivo inhibition by benserazide of clorgyline-resistant amine oxidases in rat cardiovascular tissues.苄丝肼对大鼠心血管组织中氯吉兰抗性胺氧化酶的体外和体内抑制作用。
Biochem Pharmacol. 1982 Apr 1;31(7):1417-24. doi: 10.1016/0006-2952(82)90037-5.
3
Amine oxidase activities in brown adipose tissue of the rat: identification of semicarbazide-sensitive (clorgyline-resistant) activity at the fat cell membrane.大鼠棕色脂肪组织中的胺氧化酶活性:脂肪细胞膜上氨基脲敏感(氯吉兰耐药)活性的鉴定。
J Pharm Pharmacol. 1984 Oct;36(10):652-8. doi: 10.1111/j.2042-7158.1984.tb04837.x.
4
Evidence for a clorgyline-resistant monoamine metabolizing activity in the rat heart.大鼠心脏中存在对氯吉灵耐药的单胺代谢活性的证据。
J Pharm Pharmacol. 1975 Sep;27(9):628-91.
5
Inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by mexiletine and related compounds.美西律及相关化合物对单胺氧化酶和氨基脲敏感胺氧化酶的抑制作用。
Naunyn Schmiedebergs Arch Pharmacol. 1984 Oct;327(4):273-8. doi: 10.1007/BF00506236.
6
A comparison of cardiac and vascular clorgyline-resistant amine oxidase and monoamine oxidase. Inhibition by amphetamine, mexiletine and other drugs.心脏和血管中对氯吉兰抵抗的胺氧化酶与单胺氧化酶的比较。苯丙胺、美西律及其他药物的抑制作用。
Biochem Pharmacol. 1982 Jan 1;31(1):27-35. doi: 10.1016/0006-2952(82)90231-3.
7
Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO).
J Neural Transm (Vienna). 2002 Mar;109(3):251-65. doi: 10.1007/s007020200021.
8
The deamination of n-pentylamine by monoamine oxidase and a semicarbazide-sensitive amine oxidase of rat heart.大鼠心脏中单胺氧化酶和氨基脲敏感胺氧化酶对正戊胺的脱氨基作用。
J Pharm Pharmacol. 1983 Jul;35(7):416-20. doi: 10.1111/j.2042-7158.1983.tb04314.x.
9
Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta.人脐动脉和大鼠主动脉中氨基脲敏感性胺氧化酶对甲胺的脱氨作用。
Biochem Pharmacol. 1988 Feb 15;37(4):707-13. doi: 10.1016/0006-2952(88)90145-1.
10
Properties of monoamine oxidase in monkey heart.猴心脏中单胺氧化酶的特性
Jpn J Pharmacol. 1984 Aug;35(4):425-31. doi: 10.1254/jjp.35.425.